Systematic analysis of SCN5A variants associated with inherited cardiac diseases.

SCN5A domains overlap syndrome phenotypes pleiotropy

Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
10 Aug 2024
Historique:
received: 06 06 2024
revised: 19 07 2024
accepted: 07 08 2024
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 12 8 2024
Statut: aheadofprint

Résumé

SCN5A variants are associated with a spectrum of cardiac electrical disorders with clear phenotypes. However, they may also be associated with complex phenotypic traits like overlap syndromes, or pleiotropy, which have not been systematically described. Additionally, the involvement of SCN5A in dilated cardiomyopathies (DCM) remains controversial. We aimed to (1) evaluate the different phenotypes associated with pathogenic (P)/likely pathogenic (LP) SCN5A variants and (2) determine the prevalence of pleiotropy in a large multicentric cohort of P/LP SCN5A variant carriers. The DNA of 13,510 consecutive probands (9960 with cardiomyopathies) was sequenced using a custom panel of genes. Individuals carrying a heterozygous single P/LP SCN5A variant were selected and phenotyped. The study included 170 P/LP variants found in 495 patients. Among them, 119 (70%) were exclusively associated with a single well-established phenotype: 91 with Brugada syndrome, 15 with type 3 long QT syndrome, six with progressive cardiac conduction disease, four with multifocal ectopic Purkinje-related premature contraction, and three with sick sinus syndrome. Thirty-two variants (19%) were associated with overlap syndromes and/or pleiotropy. The 19 remaining variants (11%) were associated with atypical or unclear phenotypes. Among those, eight were carried by eight patients presenting with DCM with a debatable causative genotype/phenotype link. Most P/LP SCN5A variants were found in patients with primary electrical disorders, mainly Brugada syndrome. Nearly 20% were associated with overlap syndromes or pleiotropy, underscoring the need for comprehensive phenotypic evaluation. The concept of SCN5A variants causing DCM is extremely rare (8/9960), if not questionable.

Sections du résumé

BACKGROUND BACKGROUND
SCN5A variants are associated with a spectrum of cardiac electrical disorders with clear phenotypes. However, they may also be associated with complex phenotypic traits like overlap syndromes, or pleiotropy, which have not been systematically described. Additionally, the involvement of SCN5A in dilated cardiomyopathies (DCM) remains controversial.
OBJECTIVE OBJECTIVE
We aimed to (1) evaluate the different phenotypes associated with pathogenic (P)/likely pathogenic (LP) SCN5A variants and (2) determine the prevalence of pleiotropy in a large multicentric cohort of P/LP SCN5A variant carriers.
METHODS METHODS
The DNA of 13,510 consecutive probands (9960 with cardiomyopathies) was sequenced using a custom panel of genes. Individuals carrying a heterozygous single P/LP SCN5A variant were selected and phenotyped.
RESULTS RESULTS
The study included 170 P/LP variants found in 495 patients. Among them, 119 (70%) were exclusively associated with a single well-established phenotype: 91 with Brugada syndrome, 15 with type 3 long QT syndrome, six with progressive cardiac conduction disease, four with multifocal ectopic Purkinje-related premature contraction, and three with sick sinus syndrome. Thirty-two variants (19%) were associated with overlap syndromes and/or pleiotropy. The 19 remaining variants (11%) were associated with atypical or unclear phenotypes. Among those, eight were carried by eight patients presenting with DCM with a debatable causative genotype/phenotype link.
CONCLUSION CONCLUSIONS
Most P/LP SCN5A variants were found in patients with primary electrical disorders, mainly Brugada syndrome. Nearly 20% were associated with overlap syndromes or pleiotropy, underscoring the need for comprehensive phenotypic evaluation. The concept of SCN5A variants causing DCM is extremely rare (8/9960), if not questionable.

Identifiants

pubmed: 39134129
pii: S1547-5271(24)03136-9
doi: 10.1016/j.hrthm.2024.08.018
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Alexis Hermida (A)

Cardiology, Arrhythmia, and Cardiac Stimulation Service, Amiens-Picardie University Hospital, Amiens, France; EA4666 HEMATIM, University of Picardie-Jules Verne, Amiens, France; APHP, Pitié-Salpêtrière Hospital, Institute of Cardiology and ICAN Institute for Cardiometabolism and Nutrition, Paris, France; APHP, Pitié-Salpêtrière Hospital, Department of Genetics, Department of Cardiology, and Referral center for hereditary cardiac diseases, Paris, France. Electronic address: a.hermida.jarry@gmail.com.

Guillaume Jedraszak (G)

EA4666 HEMATIM, University of Picardie-Jules Verne, Amiens, France; Molecular Genetics Laboratory, Amiens-Picardie University Hospital, Amiens, France.

Flavie Ader (F)

Unité Pédagogique de Biochimie, Département des Sciences Biologiques et Médicales, UFR de Pharmacie-Faculté de Santé; Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et Cellulaire, DMU Biogem, Service de Biochimie Métabolique, AP-HP-Sorbonne Université, Pitié-Salpêtrière -Charles Foix; Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France.

Isabelle Denjoy (I)

Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France; CNMR Maladies Cardiaques Héréditaires Rares, APHP, Hôpital Bichat, 75018 Paris, France.

Véronique Fressart (V)

Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et Cellulaire, DMU Biogem, Service de Biochimie Métabolique, AP-HP-Sorbonne Université, Pitié-Salpêtrière -Charles Foix; Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France.

Phillipe Maury (P)

Service de Cardiologie, Centre hospitalier universitaire, Toulouse, France.

Christophe Beyls (C)

Cardiology, Arrhythmia, and Cardiac Stimulation Service, Amiens-Picardie University Hospital, Amiens, France.

Adrien Bloch (A)

Unité Pédagogique de Biochimie, Département des Sciences Biologiques et Médicales, UFR de Pharmacie-Faculté de Santé; Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et Cellulaire, DMU Biogem, Service de Biochimie Métabolique, AP-HP-Sorbonne Université, Pitié-Salpêtrière -Charles Foix; Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France.

Gaël Clerici (G)

Service de Cardiologie, Centre hospitalier universitaire, Saint Pierre, La Réunion, France.

Elise Daire (E)

EA4666 HEMATIM, University of Picardie-Jules Verne, Amiens, France; Service de Pédiatrie, CHU Amiens, Amiens, France.

Pascal Defaye (P)

Service de Cardiologie, Centre hospitalier universitaire, Grenoble, France.

Delphine Dupin-Deguine (D)

Service de Génétique, CHU Toulouse, Toulouse, France.

Loic Garçon (L)

EA4666 HEMATIM, University of Picardie-Jules Verne, Amiens, France; Molecular Genetics Laboratory, Amiens-Picardie University Hospital, Amiens, France.

Didier Klug (D)

France CHU Lille, Service de Cardiologie, F-59000 Lille ; France ; Inserm UMR1011, Institut Pasteur de Lille, F-59000 Lille.

Emmanuelle Ginglinger (E)

Service de génétique, CH Mulhouse, Mulhouse, France.

Jean-Sylvain Hermida (JS)

Cardiology, Arrhythmia, and Cardiac Stimulation Service, Amiens-Picardie University Hospital, Amiens, France.

Laurence Jesel (L)

Service de Cardiologie, CHU Strasbourg, Strasbourg, France.

Diala Khraiche (D)

AP-HP, Pédiatrie, Hôpital Necker, Paris, France.

Maciej Kubala (M)

Cardiology, Arrhythmia, and Cardiac Stimulation Service, Amiens-Picardie University Hospital, Amiens, France.

Jérôme Lacotte (J)

Service de Cardiologie, Institut Jacques Cartier, Massy, France.

Mikael Laredo (M)

APHP, Pitié-Salpêtrière Hospital, Institute of Cardiology and ICAN Institute for Cardiometabolism and Nutrition, Paris, France; APHP, Pitié-Salpêtrière Hospital, Department of Genetics, Department of Cardiology, and Referral center for hereditary cardiac diseases, Paris, France; Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France.

Antoine Leenhardt (A)

Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France; CNMR Maladies Cardiaques Héréditaires Rares, APHP, Hôpital Bichat, 75018 Paris, France.

Xavier Le Guillou (X)

CHU de Poitiers, Service de Génétique Médicale, F- 86000 Poitiers, France.

Francois Lesaffre (F)

Service de Cardiologie, CHU Reims, Reims, France.

Alice Maltret (A)

Service de Cardiopathie Congénitale, GHPSJ Hôpital Marie Lannelongue, Le Plessis Robinson, France.

Isabelle Magnin-Poull (I)

Service de Cardiologie, CHU Nancy, Nancy, France.

Eloi Marijon (E)

Service de Cardiologie, Hôpital Européen Georges Pompidou, APHP, France; Université Paris Cité, INSERM, PARCC, F-75015 Paris, France.

Sophie Nambot (S)

Centre de Référence Anomalies du Développement et Syndromes Malformatifs, FHU TRANSLAD, Hôpital d'Enfants, Dijon, France.

Nathalie Neyroud (N)

Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France.

Sandro Ninni (S)

France CHU Lille, Service de Cardiologie, F-59000 Lille ; France ; Inserm UMR1011, Institut Pasteur de Lille, F-59000 Lille.

Aurélien Palmyre (A)

APHP, Ambroise Paré Hospital, Department of Genetics and Referral center for cardiac hereditary cardiac diseases, Boulogne-Billancourt, France.

Jean Luc Pasquie (JL)

Service de Cardiologie, CHU Montpellier, Montpellier, France; PHYMEDEXP-CNRS UMR9214, Inserm U1046, Université de Montpellier et CHU de Montpellier, Montpellier, France.

Julie Proukhnitzky (J)

APHP, Pitié-Salpêtrière Hospital, Institute of Cardiology and ICAN Institute for Cardiometabolism and Nutrition, Paris, France; APHP, Pitié-Salpêtrière Hospital, Department of Genetics, Department of Cardiology, and Referral center for hereditary cardiac diseases, Paris, France; Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France.

Patricia Reant (P)

Service de cardiologie, LIRYC Institute, Bordeaux University Hospital, Univ. Bordeaux, Referral Center for Rare and inherited Cardiomyopathies, Bordeaux, France.

Pascale Richard (P)

Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et Cellulaire, DMU Biogem, Service de Biochimie Métabolique, AP-HP-Sorbonne Université, Pitié-Salpêtrière -Charles Foix; Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France.

Anne Rollin (A)

Service de Cardiologie, Centre hospitalier universitaire, Toulouse, France.

Caroline Rooryck (C)

CHU Bordeaux, Service de Génétique Médicale, F-33000 Bordeaux, France.

Frédéric Sacher (F)

Service de rythmologie, LIRYC Institute, Bordeaux University Hospital, CRMR Cardiogen, ERN Guard-Heart, INSERM 1045 Univ. Bordeaux, Bordeaux, France.

Elise Schaefer (E)

Service de Génétique médicale, Institut de génétique médicale d'Alsace, CHU Strasbourg, Strasbourg, France.

Agathe Vernier (A)

Victor Pauchet Clinic, Amiens, France.

Pierre-François Winum (PF)

Service de Cardiologie, CHU Nîmes, Nîmes, France.

Karim Wahbi (K)

Service de Cardiologie, CHU Cochin, APHP, France.

Xavier Waintraub (X)

APHP, Pitié-Salpêtrière Hospital, Institute of Cardiology and ICAN Institute for Cardiometabolism and Nutrition, Paris, France; APHP, Pitié-Salpêtrière Hospital, Department of Genetics, Department of Cardiology, and Referral center for hereditary cardiac diseases, Paris, France.

Victor Waldmann (V)

Service de Cardiologie, Hôpital Européen Georges Pompidou, APHP, France; Université Paris Cité, INSERM, PARCC, F-75015 Paris, France.

Sacha Weber (S)

Service de Génétique, CHU Caen, Caen, France.

Amir Zouaghi (A)

Service de Cardiologie, CH d'Antibes, Antibes, France.

Philippe Charron (P)

APHP, Pitié-Salpêtrière Hospital, Department of Genetics, Department of Cardiology, and Referral center for hereditary cardiac diseases, Paris, France; Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France; APHP, Ambroise Paré Hospital, Department of Genetics and Referral center for cardiac hereditary cardiac diseases, Boulogne-Billancourt, France.

Fabrice Extramiana (F)

Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France; CNMR Maladies Cardiaques Héréditaires Rares, APHP, Hôpital Bichat, 75018 Paris, France; Université Paris Cité, Paris, France.

Estelle Gandjbakhch (E)

APHP, Pitié-Salpêtrière Hospital, Institute of Cardiology and ICAN Institute for Cardiometabolism and Nutrition, Paris, France; APHP, Pitié-Salpêtrière Hospital, Department of Genetics, Department of Cardiology, and Referral center for hereditary cardiac diseases, Paris, France; Sorbonne Université, Inserm, Research Unit on Cardiovascular and Metabolic Diseases, UMRS-1166, Paris, France.

Classifications MeSH